Nicholas C Grassly Selected Research

acute flaccid myelitis

1/2018	Population sensitivity of acute flaccid paralysis and environmental surveillance for serotype 1 poliovirus in Pakistan: an observational study.
1/2018	Type 2 Poliovirus Detection after Global Withdrawal of Trivalent Oral Vaccine.
1/2018	Routine immunization in Pakistan: comparison of multiple data sources and identification of factors associated with vaccination.
10/2016	Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data.
2/2014	Key issues in the persistence of poliomyelitis in Nigeria: a case-control study.
8/2012	The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis.
5/2012	Waning intestinal immunity after vaccination with oral poliovirus vaccines in India.
9/2009	Mucosal immunity after vaccination with monovalent and trivalent oral poliovirus vaccine in India.
10/2008	Effectiveness of immunization against paralytic poliomyelitis in Nigeria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicholas C Grassly Research Topics

Disease

22	Poliomyelitis (Polio) 01/2022 - 04/2007
9	Infections 08/2022 - 04/2007
9	acute flaccid myelitis 01/2018 - 10/2008
5	Trachoma 01/2015 - 06/2007
3	Paralysis (Palsy) 01/2022 - 10/2008
3	Blindness (Hysterical Blindness) 01/2015 - 06/2007
2	COVID-19 08/2022 - 09/2021
1	Breakthrough Infections 08/2022
1	Asymptomatic Infections 08/2022
1	Typhoid Fever (Typhoid) 11/2021
1	Fatigue 07/2020
1	Dysbiosis 01/2018
1	Malnutrition (Nutritional Deficiencies) 01/2018
1	Trichiasis 01/2015
1	Cicatrix (Scar) 01/2015
1	Inflammation (Inflammations) 01/2015
1	Diarrhea 09/2014
1	Enterovirus Infections 05/2012
1	Reinfection 01/2009
1	Acquired Immunodeficiency Syndrome (AIDS) 07/2002

Drug/Important Bio-Agent (IBA)

23	VaccinesIBA 08/2022 - 04/2007
10	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 01/2022 - 10/2008
7	Poliovirus VaccinesIBA 01/2016 - 04/2007
6	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 06/2007
2	AntibodiesIBA 08/2022 - 01/2018
2	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 01/2015 - 01/2012
1	Ad26COVS1IBA 08/2022
1	dimethylaminonaphthalene- 5- sulfonaminoethylmethylamine (DDNS)IBA 01/2022
1	Blood Group Antigens (Blood Groups)IBA 01/2018
1	Measles VaccineIBA 01/2018
1	Viral ProteinsIBA 01/2018
1	Combined VaccinesIBA 01/2018
1	WastewaterIBA 01/2018
1	insulin receptor-related receptor (IRR)IBA 01/2017
1	EpitopesIBA 01/2008
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2008
1	dimemorfan (AT 17)IBA 01/2008
1	Immunoglobulin A (IgA)IBA 01/2008

Therapy/Procedure

2	Mass Drug Administration 11/2010 - 01/2009
1	Therapeutics 07/2002